Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

New Phase 1 trial launches to evaluate IAVI-developed HIV broadly neutralizing antibody

July 7, 2026

PedMab1-Ex, led by SAMRC and Ospedale San Raffaele, aims to assess ePGT121v1-LS for eventual use to prevent HIV acquisition by infants and young children.

Read more

Features

Vaccination induces HIV bnAbs in primates, bolstering germline-targeting strategy

July 6, 2026

New study published in Nature shows for the first time elicitation of broadly neutralizing antibodies to HIV in a stringent animal model.

Read more

Advancing Global Health Innovation through Europe-Africa Collaboration

Eight Product Development Partnerships (PDPs) are joining forces to call for sustained investment in the European and Developing Countries Clinical Trials Partnership (EDCTP) under the next EU Framework Programme for Research and Innovation and other EU funding frameworks under discussion.

Read more

Features

Optimizing antibodies for antimicrobial resistance

June 29, 2026

IAVI harnesses its prowess in antibody isolation, engineering, and optimization to expand its portfolio of vaccines and monoclonal antibodies against multiple bacterial pathogens.

Read more

In The News

Scientists race for a new Ebola vaccine: The most promising candidates against strain

Al Jazeera

June 26, 2026

Read more

In The News

Ebola Outbreak Puts Spotlight on Trump’s America First Health Strategy

Bloomberg Next Africa

June 26, 2026

Read more

In The News

Why existing vaccines won’t help this Ebola outbreak

National Geographic

June 15, 2026

Read more

In The News

Ebola is back. So are the double standards

Bhekisisa Centre for Health Journalism

June 11, 2026

Read more